Open menu
Paytm Money logo
search-placeholder
search
Mutual Fund Details
search-placeholder
search
ICICI Prudential Mutual Fund

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

NAV
returns change indicator
16.0600
as on 10 Aug 2020, 11:30 PM
0.6400(4.15%)
Last Change
loaderloader

Start SIP in this Mutual Fund

Min SIP Amount
100
Suggested Date
20th of Every Month

Investment Performance

would have given a return of
103,499
star
106,749
star
161,761
star
164,103
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
64,102
Profit (absolute return)
64.10%
in the last
1m
3m
1y
max
+1% Higher Returns
With Direct Plans on Paytm Money

Investment Returns

In the last 3 months
29.10%
In the last 6 months
42.12%
In the last 1 year
64.10%
In the last 3 years
NA
In the last 5 years
NA
In the last 10 years
NA
Absolute Returns
CAGR

Scheme Riskometer

low
low
moderately low
moderately low
moderate
moderate
moderately high
moderately high
high
high
indicator
Investors understand that their principal will be at high risk

Scheme Information

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
as of 30 Jun 2020, 05:30 AM
1,522.96 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 15 days.
1.37%
Expense Ratio
Plan
Growth
8.33%
Cash Holding
Benchmark
S&P BSE Healthcare Total Return Index
Scheme Document
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 15 days.
Scheme Document

Sectors Holding in this Mutual Fund

as on 30 Jun 2020
Sort By
Healthcare
86.38%
1,315.57 Cr
Cash Holding
8.33%
126.79 Cr
Financial
2.49%
37.90 Cr
Chemicals
1.63%
24.87 Cr

Companies Holding in this Mutual Fund

as on 30 Jun 2020
Sort By
Cipla Ltd.
10.79%
164.33 Cr
Sun Pharmaceutical Inds. Ltd.
9.87%
150.32 Cr
Others
8.47%
128.99 Cr
Lupin Ltd.
7.34%
111.79 Cr
Dr. Reddy's Laboratories Ltd.
4.69%
71.43 Cr
Biocon Ltd.
4.39%
66.86 Cr
JB Chemicals & Pharmaceuticals Ltd.
4.10%
62.44 Cr
Sanofi India Ltd.
3.89%
59.24 Cr
Natco Pharma Ltd.
3.87%
58.94 Cr
Cadila Healthcare Ltd.
3.58%
54.52 Cr
View All
View All

About ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth is a Equity mutual fund scheme from ICICI Prudential Mutual Fund. This scheme was launched on 13 Jul 2018 and is currently managed by its fund manager Dharmesh Kakkad. It has an AUM of ₹1,522.96 Crores and the latest NAV decalared is ₹16.060 as on 12 Aug 2020 at 3:29 am.
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth scheme return performance in last 1 year is 64.10%, is 62.22% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.

Scheme Details

AUM:1,522.96 Cr
Category:Equity: Sectoral-Pharma
Launch Date:13 Jul 2018
Fund Type:Open-End

Scheme Objective

The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.

AMC Information

Address
Address
One BKC , A Wing ,13th Floor, Bandra Kurla Complex,400051
Phone Number
Phone Number
Phone : 022-26525000 / 1800-222-999 / 1800-200-6666
Fax : 022-26528100